CINtec Plus is an advanced cervical cancer screening test that detects the simultaneous presence of p16 and Ki-67 proteins in the same cervical cell. Their co-expression suggests abnormal cell cycle changes associated with high-risk HPV infection and an increased likelihood of cervical precancer. It is commonly used to help identify women who may need further evaluation after HPV-positive results or abnormal cervical screening.
Why is this test done?
Helps identify women at increased risk of cervical precancer (CIN2+)
Evaluates HPV-related cellular changes
Assists in deciding whether colposcopy is needed
Improves accuracy when used alongside HPV and Pap tests
Supports early detection and timely management of cervical abnormalities
Who should consider this test?
Women with a positive high-risk HPV test
Individuals with equivocal or mildly abnormal Pap smear results (e.g., ASC-US, LSIL)
Patients requiring further assessment before colposcopy
Women under cervical cancer screening follow-up as advised by their gynecologist
Sample Required
Cervical cell sample collected during a routine cervical examination (liquid-based cytology).
Preparation
No fasting required.
Avoid vaginal medications, douching, or sexual intercourse for 24–48 hours before sample collection, if advised by your healthcare provider.
Benefits
Early detection of cervical precancerous changes
Better risk assessment than HPV testing alone in selected patients
Helps reduce unnecessary colposcopies
Supports personalized clinical management
Reliable and evidence-based screening aid
Book Your Test Today
Protect your cervical health with advanced screening. Early detection can make a significant difference. Consult your healthcare provider to know if the CINtec Plus test is right for you.